首页> 外文期刊>OncoTargets and therapy >Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience
【24h】

Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience

机译:年龄对肝细胞癌患者肝移植后预后的影响:单中心经验

获取原文
       

摘要

Background: Liver transplantation (LT) offers the most effective treatment for hepatocellular carcinoma patients. Various preoperative variables are correlated with survival after LT, but the prognostic role of aging on LT remains controversial. Methods: Between January 2001 and December 2011, 290 consecutive transplants for patients with hepatocellular carcinoma performed in Shanghai First People’s Hospital (People’s Republic of China) were analyzed retrospectively. We compared patient characteristics and survival curves between a younger group (less than 49 years, n=135) and an aged group (50 years or older, n=155). We then performed Cox multivariate regression analysis of the risk factors for survival in aged and younger patients. Results: Younger age was associated with higher alpha-fetoprotein ( P =0.014), larger tumor size ( P =0.038), poorer differentiation ( P =0.025), portal lymph node metastasis ( P =0.001), and higher recurrence rate ( P =0.038). Aged patients had significantly longer recurrence-free survival and overall survival ( P =0.020 and P =0.014, respectively); however, there were no significant differences between the younger and aged patients who met the Milan criteria ( P >0.05). The 1-, 3-, and 5-year recurrence-free survival rates were 59.7%, 44.5%, and 37.3%, respectively, in the younger group, and 67.9%, 55.3%, and 53.8%, respectively, in the aged group. The 1-, 3-, and 5-year overall survival rates were 68.4%, 45.5%, and 38.9%, respectively, in the younger group, and 76.1%, 59.7%, and 53.9%, respectively, in the aged group. Alpha-fetoprotein?≥400?ng/mL, microvascular invasion, and tumor size >5 cm were independent risk factors for prognosis in both groups. Conclusion: Younger patients in our center tended to present with more aggressive tumors and have a higher risk of recurrence. Our single-center experience suggests that younger patients should be assessed more rigorously before LT, while aged patients should be actively considered for LT after appropriate selection.
机译:背景:肝移植(LT)为肝细胞癌患者提供了最有效的治疗方法。各种术前变量与LT后的存活率相关,但衰老对LT的预后作用仍存在争议。方法:回顾性分析2001年1月至2011年12月在上海市第一人民医院进行的290例肝细胞癌患者的连续移植手术。我们比较了年轻组(小于49岁,n = 135)和老年组(50岁或更大,n = 155)之间的患者特征和生存曲线。然后,我们对老年和年轻患者生存的危险因素进行了Cox多变量回归分析。结果:年龄越小,甲胎蛋白水平越高(P = 0.014),肿瘤大小越大(P = 0.038),分化越差(P = 0.025),门淋巴结转移(P = 0.001)和复发率越高(P = 0.038)。老年患者的无复发生存期和总生存期明显更长(分别为P = 0.020和P = 0.014);但是,符合米兰标准的年轻和老年患者之间没有显着差异(P> 0.05)。年轻组的1年,3年和5年无复发生存率分别为59.7%,44.5%和37.3%,老年组分别为67.9%,55.3%和53.8%。组。年轻组的1年,3年和5年总生存率分别为68.4%,45.5%和38.9%,老年组分别为76.1%,59.7%和53.9%。甲胎蛋白≥400?ng / mL,微血管浸润和肿瘤大小> 5 cm是两组预后的独立危险因素。结论:我们中心的年轻患者倾向于表现出更具侵略性的肿瘤,并且具有更高的复发风险。我们的单中心的经验表明,年轻患者应LT以前更严格评估,而老年患者应经过适当选择积极考虑LT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号